Skip to main content
TipRanks
Go Ultimate75% OFF

Armata Pharmaceuticals (TG1N) Stock Statistics & Valuation Metrics

1 Followers

Total Valuation

Armata Pharmaceuticals has a market cap or net worth of EUR 101.17M. The enterprise value is EUR 463.30M.

Market Cap
EUR 101.17M
Enterprise Value
EUR 463.30M

Share Statistics

Armata Pharmaceuticals has 37,192,630 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
37,192,630
Owned by Insiders
0.60%
Owned by Institutions
12.93%

Financial Efficiency

Armata Pharmaceuticals’s return on equity (ROE) is 0.80 and return on invested capital (ROIC) is -43.07%.

Return on Equity (ROE)
0.80
Return on Assets (ROA)
-2.26
Return on Invested Capital (ROIC)
-43.07%
Return on Capital Employed (ROCE)
-0.46
Revenue Per Employee
80.39K
Profits Per Employee
-2.85M
Employee Count
61
Asset Turnover
0.06
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Armata Pharmaceuticals is -0.73. Armata Pharmaceuticals’s PEG ratio is 0.00.

PE Ratio
-0.73
PS Ratio
14.37
PB Ratio
0.00
Price to FCF
-3.46
Price to Operating Cash Flow
-3.49
PEG Ratio
0.00

Income Statement

In the last 12 months, Armata Pharmaceuticals had revenue of 4.90M and earned -173.80M in profits. Earnings per share was -4.80.

Revenue
4.90M
Gross Profit
3.37M
Operating Income
-31.22M
Pretax Income
-173.80M
Net Income
-173.80M
EBITDA
-155.68M
Earnings Per Share (EPS)
-4.80

Cash Flow

In the last 12 months, operating cash flow was -26.64M and capital expenditures -223,000, giving a free cash flow of -26.86M billion.

Operating Cash Flow
-26.64M
Free Cash Flow
-26.86M
Free Cash Flow per Share
-0.72

Dividends & Yields

Armata Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-27.05%
Earnings Yield
-111.45%

Stock Price Statistics

Beta
1.51
52-Week Price Change
-43.67%
50-Day Moving Average
3.29
200-Day Moving Average
5.89
Relative Strength Index (RSI)
56.61
Average Volume (3m)
370

Important Dates

Armata Pharmaceuticals upcoming earnings date is Mar 18, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 12, 2026
Next Earnings Date
Mar 18, 2027
Ex-Dividend Date
―

Financial Position

Armata Pharmaceuticals as a current ratio of 1.19, with Debt / Equity ratio of -131.76%

Current Ratio
1.19
Quick Ratio
1.19
Debt to Market Cap
1.13
Net Debt to EBITDA
-1.79
Interest Coverage Ratio
-1.88

Taxes

In the past 12 months, Armata Pharmaceuticals has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Armata Pharmaceuticals EV to EBITDA ratio is -3.96, with an EV/FCF ratio of -12.38.

EV to Sales
51.40
EV to EBITDA
-3.96
EV to Free Cash Flow
-12.38
EV to Operating Cash Flow
-12.48

Balance Sheet

Armata Pharmaceuticals has EUR 18.32M in cash and marketable securities with EUR 251.58M in debt, giving a net cash position of -EUR 233.27M billion.

Cash & Marketable Securities
EUR 18.32M
Total Debt
EUR 251.58M
Net Cash
-EUR 233.27M
Net Cash Per Share
-EUR 6.27
Tangible Book Value Per Share
-EUR 5.05

Margins

Gross margin is 74.96%, with operating margin of -622.92%, and net profit margin of -1710.14%.

Gross Margin
74.96%
Operating Margin
-622.92%
Pretax Margin
-1710.14%
Net Profit Margin
-1710.14%
EBITDA Margin
-1298.61%
EBIT Margin
-1330.11%

Analyst Forecast

The average price target for Armata Pharmaceuticals is EUR 15.92, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
EUR 15.92
Price Target Upside
371.02% Upside
Analyst Consensus
Moderate Buy
Analyst Count
2
Revenue Growth Forecast
43.97%
EPS Growth Forecast
-156.79%

Scores

Smart Score
7
AI Score
―